This week the US Food and Drug Administration approved the release of fingolimod (trade name Gilenya®), the first oral medication for the treatment of remitting relapsing multiple sclerosis. Swedish Neuroscience Institute is proud to have participated in the pivotal clinical trial that led to the approval of Gilenya. Gilenya is a welcome addition to the set of medications available to patients living with MS. There are currently five injectable therapies and two intravenous therapies approved by the FDA for the treatment of MS. Although these treatments are very effective, many patients have been hoping for an oral alternative. Some patients are finding that they have “injection fatigue” or are running out of places to inject the medication. It is important to note, however, that not all patients should switch to Gilenya. Patients with stable disease should remain on their medications. Patients need to be informed of the risks associated with Gilenya, including slowed heart rate, increased blood pressure, difficulty breathing, abnormal liver function, and infection, and how these risks may apply to them. If you are wondering whether Gilenya is right for you, please ask your neurologist.
In my first video I talk about why I am doing this and what I hope the outcome will be. Please comment.
Most Recent Articles
Experts at Swedish share the benefits of lung cancer screening and innovative technology that improves diagnosis and treatment options.
National Handwashing Awareness Week is December 1 through 7. Flu and other respiratory viruses are spreading, so let's reinforce the importance of handwashing.
A Swedish expert offers advice on symptoms, treatment and more.
If you are living with essential tremor, Swedish movement disorder specialists offer customized treatment to get you back to the activities you love.
When an illness or injury is sudden, it can be hard to know the right place to seek treatment. Learn more about your options for care.
Check here for the latest information on winter storm closures and operations changes.
Hospice and palliative care supports quality of life patients with serious illnesses. Hear from a Swedish provider who has dedicated her career to it.
Try this exercise to help reflect on the positive parts of your day and boost your mood.
If a loved one has a stroke, what will your role as a caregiver be? A Swedish employee shares what happened when her partner needed emergency stroke care.
A Certified Diabetes Educator from Swedish answers frequently asked questions and shares strategies to prevent this serious chronic illness.
Holiday meals are delicious, but they can trigger acid reflux and GERD. Find out how to navigate them so GERD doesn’t get in the way of your holiday fun.
November 17 is the Great American Smokeout, an event that challenges smokers to quit for the day and take the first step towards a tobacco-free life.
Swedish Issaquah caregivers turn an outdoor space into a thriving garden and donate the crops to a local food bank.
Scores of Swedish caregivers have served in the U.S. Armed Forces.
Awards for Swedish Cherry Hill, First Hill and Issaquah include seven five-star ratings.
The Small Baby Unit provides highly skilled and specialized care for extremely preterm infants born before 28 weeks.
A patient with advanced skin cancer shares how innovative treatment at Swedish Cancer Institute helped him beat the odds.
A Swedish caregiver shares their story of finding love, acceptance and community.
A team of 23 chaplains serves Swedish and is available to help provide spiritual support for every patient. Learn more.
The CDC recommends that everyone six months and older get a flu vaccine by the end of October.